Targeting metabolism to develop new prostate cancer treatments

The next generation of prostate cancer therapies is targeted at metabolism. A cascade of biochemical reactions inside the cell is being observed and reviewed by scientists, with a focus on an enzyme considered a master regulator of metabolism. By doing so, scientists hope that new research will unlock more effective and less harmful treatments. With approximately one out of six American men being diagnosed and nearly a quarter of a million new cases expected this year, prostate cancer is the most common malignancy among men in the U.S.

Read the whole article on Science Daily

More from Science Daily